Andrey Belousov

Kharkiv National Medical University

Title: Protective Role of Magnetite Nanoparticles (ICNB) in Maintaining the Molecular Integrity of Erythrocyte Protein-Lipid Membranes

---

Biography

Andrey Belousov PhD, DM, Professor - a Ukrainian medical scientist and pioneer in nanotechnology, who developed the world’s first biocompatible nanomedical drugs (Micromage-B, MCS-B, ICNB), officially registered and introduced into clinical practice since 1998. His work established a translational foundation for medical nanotechnology, linking fundamental biophysics with clinical applications in detoxification, hemocorrection, and neuroprotection. The published more 360 scientific works on results application of nanotechnology preparation in experimental and practical medicine. At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies, Professor of Department Anesthesiology, Intensive Care and Pediatric Anesthesiology of Kharkiv National Medical University, Ukraine. His research interests include nanomedicine, detoxification technologies, critical care pharmacology, and blood rheology correction. He continues to lead multidisciplinary research on the clinical application of nanostructured materials in medicine, contributing to the advancement of personalized and non-invasive therapies.

Abstract